KEYNOTE-045: Randomized phase 3 trial of pembrolizumab (MK-3475) versus paclitaxel, docetaxel, or vinflunine for previously treated metastatic urothelial cancer Meeting Abstract
| Authors: | Bellmunt, J.; Sonpavde, G.; De Wit, R.; Choueiri, T. K.; Siefker-Radtke, A. O.; Plimack, E. R.; Lewis, N. M.; Brown, H.; Mai, Y. B.; Gause, C. K.; Kaufman, D. R.; Bajorin, D. F. |
| Abstract Title: | KEYNOTE-045: Randomized phase 3 trial of pembrolizumab (MK-3475) versus paclitaxel, docetaxel, or vinflunine for previously treated metastatic urothelial cancer |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036904763 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.tps4571 |
| Notes: | Meeting Abstract: TPS4571 -- Source: Wos |
